Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1126.8000 -3.50 (-0.31%)
NSE Oct 13, 2025 13:18 PM
Volume: 1.1M
 

1126.80
-0.31%
Prabhudas Lilladhar
resolution three times in past 18 months showcased commitment and cohesive organizational structure that professionally manages processes without dependence on key personnel. Noticing the operational risk among large peers in key markets, ARBP strategically envisaged alleviation of concentration risk and regulatory risk on key products/ plants/ markets. It's newly commissioned Unit-16, made to replicate products of Unit-12 for US market, additionally supplies injectable...
Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings
More from Aurobindo Pharma Ltd.
Recommended